They Just Don't Get...
Health Care: Drugs
GlaxoSmithKline PLC (GSK: NYSE)
$45.06 0.71 | 1.60%
02/09/12 - 04:01 PM ET
3.01M / 2.51M
Vol / Avg. Vol:44.91 / 44.35
Open / Prev. Close:44.71 - 45.14
Today's Range:36.39 - 46.50
52 Wk Range:-1.25%
Performance YTD:TheStreet Rating:
Portfolios with GSK
- Portfolio NameUser Type
- User2012 performers
- UserW FRAZIER BRINLEY Portfolio 1
- User2012 WFB Favorite Portfolio
- UserFunds For Future
- Userpauls picks
- ContributorHighest-Yielding Drug Stocks
- Userwarrens picks
- ContributorBest British Stocks for 2012
- ProWarren Buffett
- ContributorThanksgiving Stocks Portfolio
Latest GSK Headlines from TheStreet
- GlaxoSmithKline Plc's CEO Discusses Q4 2011 Results - Earnings Call Transcript 02.07.12 | 03:02 pm
- Stocks to Watch: Coca-Cola, BP (Update 1) 02.07.12 | 08:02 am
- Verastem IPO Looks Like Risky Bet 01.26.12 | 07:01 am
- IPO: Unproven Verastem
01.26.12 | 05:01 am - 'Fast Money' Recap: JPMorgan's Tell 01.12.12 | 08:01 pm
- Theravance Shares Slide on Lung Drug Deaths 01.09.12 | 09:01 am
- GlaxoSmithKline Stock Hits New 52-Week High (GSK) 01.03.12 | 11:01 am
- GlaxoSmithKline Stock Hits New 52-Week High (GSK) 12.23.11 | 10:12 am
- GlaxoSmithKline PLC (GSK): Today's Featured Health Care Loser 12.16.11 | 04:12 pm
- GlaxoSmithKline PLC (GSK): Today's Featured Health Care Winner 12.07.11 | 05:12 pm
Press Releases for GSK
- Siemens Forms New Companion Diagnostics Partnerships With ViiV Healthcare And Tocagen - PR Newswire 02.07.12 | 11:02 am
- GSK Upbeat On Solid Results - Interviews With CEO And CFO - PR Newswire 02.07.12 | 07:02 am
- The New England Journal Of Medicine Publishes Study Showing LigoCyte's Norovirus Vaccine Demonstrates Protection Against Illness - PR Newswire 12.08.11 | 07:12 am
- Isis Selects Development Candidate, Isis-AATRx, To Treat AATD-Associated Liver Disease - PR Newswire 10.11.11 | 08:10 am
- Regulatory Update: GSK And XenoPort Submit Supplemental New Drug Application To FDA For Horizant™ In Postherpetic Neuralgia - Business Wire 08.09.11 | 04:08 pm
- GlaxoSmithKline Pledges $10 Million At White House Meeting On US Education Reform - PR Newswire 07.18.11 | 01:07 pm
- GlaxoSmithKline Receives FDA Approval For BOOSTRIX® To Help Prevent Whooping Cough In Adults 65 Years And Older - PR Newswire 07.08.11 | 10:07 pm
- Video From GlaxoSmithKline And Synaptic Digital: GlaxoSmithKline Receives FDA Approval For BOOSTRIX® To Help Prevent Whooping Cough In Adults 65 Years And Older - PR Newswire 07.08.11 | 07:07 pm
- GlaxoSmithKline Implements Next Phase Of New Incentive Compensation Program For U.S. Sales Representatives - PR Newswire 07.05.11 | 09:07 am
- Isis Earns $3 Million Payment As Collaboration With GSK Expands - PR Newswire 05.16.11 | 08:05 am
Partner Headlines for GSK
- Incivek Catalyst at Play for Vertex - Analyst Blog - Zacks 02.03.12 | 10:02 am
- Response Genetics Stock Soars 31% On $7.8M Offering News - Seeking Alpha 02.03.12 | 08:02 am
- Verastem IPO Validates Investor Interest In Cancer Stem Cell Approach - Seeking Alpha 01.30.12 | 09:01 am
- 5 Excellent Dividend Stocks For Retirement Income - Seeking Alpha 01.24.12 | 09:01 am
- Taking a Closer Look at Investing in Singapore - Benzinga 01.17.12 | 01:01 pm
- Keeping An Eye On Isis - Seeking Alpha 01.13.12 | 07:01 pm
- In Search Of Rising Dividends: GlaxoSmithKline PLC - Seeking Alpha 01.13.12 | 08:01 am
- Analyzing 5 Biotech Stocks And Their Takeover Potential - Seeking Alpha 01.13.12 | 08:01 am
- Vivus' Obesity Drug Label Modified - Analyst Blog - Zacks 01.12.12 | 10:01 am
- Can These 5 Pharma Stocks Keep Paying Big Dividends? - Seeking Alpha 01.11.12 | 09:01 am
